OTC/Supplement Combo Products Are In “Regulatory Limbo” – Attorney
This article was originally published in The Tan Sheet
Executive Summary
FDA should include OTC drug/dietary supplement combinations in its combination products guidelines and place them under the jurisdiction of the Office of Combination Drugs, attorney Ralph Fucetola recommends
You may also be interested in...
OTC/Supplement Co-Packaging Policy In The Works At FDA
Any future FDA guidance or regulation on co-packaging OTCs with dietary supplements would have to reflect the agency's resolution of concerns related to duration of use, dual-labeling and multiple claims for such products
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands